Recommendation for ISTH/SSC Criterion 2015 for autoimmune acquired factor XIII/13 deficiency

Akitada Ichinose; Hans P. Kohler; Helen Philippou

doi:10.1160/TH16-05-0362

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2016; 116(04): 772-774
DOI: 10.1160/TH16-05-0362

Letter to the Editor

Schattauer GmbH

Recommendation for ISTH/SSC Criterion 2015 for autoimmune acquired factor XIII/13 deficiency

Authors

Akitada Ichinose

¹Department of Molecular Patho-Biochemistry, Yamagata University School of Medicine, Yamagata, Japan
Hans P. Kohler

²Experimental Haemostasis Group, Department of Clinical Research, University of Bern, and Department of Internal Medicine, Tiefenauspital, Inselgruppe AG, Switzerland
Helen Philippou

³Section on Mechanisms of Thrombosis, Leeds Institute for Health, Genetics and Therapeutics, University of Leeds, Leeds, UK

Abstract

Supplementary Material to this article is available online at www.thrombosis-online.com.

Full Text

References

References
1 Ichinose A.. Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited. Semin Thromb Hemost 2011; 37: 382-388.
2 Lorand L.. Acquired Inhibitors of Fibrin Stabilization: A Class of Hemorrhagic Disorders of Diverse Origins. In: Green D. ed. Anticoagulants Physiologic, Pathologic, and Pharmacologic. CRC Press; 1994: 169-191.
3 Egbring R, Kröniger A, Seitz R.. Erworbene inhibitoren gegen Faktor XIII.. Hamostaseologie 1996; 16: 174-179.
4 Ichinose A. Japanese Collaborative Research Group (JCRG) on AH13 Hemorrhagic Acquired Coagulopathies. Inhibitors of Factor XIII/13 in older patients. Semin Thromb Hemost 2014; 40: 704-711.
5 Souri M, Osaki T, Ichinose A.. Anti-factor XIII A subunit (FXIII-A) autoantibodies block FXIII-A2B2 assembly and steal FXIII-A from native FXIII-A2B2. J Thromb Haemost 2015; 13: 802-814.
6 Rodeghiero F, Tosetto A, Abshire T. et al. ISTH/ SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 08: 2063-2065.
7 Schulman S, Kearon C. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 03: 692-694.
8 Baudo F, Collins P, Huth-Kühne A. et al. EACH2 registry contributors. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood 2012; 120: 39-46.
9 Kohler HP, Ichinose A, Seitz R. et al. on behalf of the Factor XIII And Fibrinogen SSC Subcommittee Of The ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011; 09: 1404-1406.
10 Huth-Kühne A, Baudo F, Collins P. et al International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009; 94: 566-575.

Supplementary Material

Online Supplementary Material (PDF) (PDF)